Our President and Chief Technology Officer, Dr. Anton Iliuk, recently spoke with Indiana Business about our funding for Parkinson’s and Alzheimer’s research. He shared about our […]
In this article from Dr. Anton Iliuk et al., you’ll learn about the viability of monitoring cancer biomarkers with plasma EV phosphoproteomics and chemical affinity purification. […]
In this post, you can read the introduction of Dr. Anton Iliuk’s recent Scientia publication: “A Non-Invasive, Low-Cost Procedure to Detect Cancer Biomarkers from Biological Fluids.” “Liquid […]